Nephros, Inc. (NEPH)
$3.59+0.56%Close
SELLCRISIS · day 12
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $39M
- Beta
- 1.64
- P/E (TTM)
- 22.34
- Short % float
- 0.27%
- Days to cover
- 1.4
- SI change
- -45.5%
- 1W
- +18.87%
- 1M
- -18.96%
- vs SPY 1W
- +19.01%
- vs SPY 1M
- -21.47%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 58
- VALUE
- 29
- GROWTH
- 64
- GARP
- 91
- TYPE
- Growth Compounder
Composite of Value · Growth · GARP
ROIC9.7%
REV YoY-
ROE16.2%
EPS YoY-
ROA11.0%
GROSS60
OP8
NET8
[VALUATION]
P/E TTM22.34
P/E FWD15.63
SECTOR PE20.34
INDUSTRY PE45.85
P/B3.26
P/FCF-
EV/EBITDA19.37
EV/EBIT-
PEG0.24
FCF YIELD-
RISK
INT COV-
D/E7.29
ALTMAN Z-
CURR RATIO4.07
ND/EBITDA-
BETA1.64
Company news
FAQ
- What is LOPJLB’s current signal on NEPH?
- LOPJLB’s latest quantitative signal on Nephros, Inc. (NEPH) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NEPH in?
- Nephros, Inc. (NEPH) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Nephros, Inc. (NEPH) do?
- Nephros, Inc. is a company that specializes in developing and marketing sophisticated water purification solutions across the United States, catering to both the medical and commercial sectors. Its operations are structured into three primary segments: Water Filtration, Pathogen Detection, and Renal Products. Within its Water Filtration division, Nephros offers advanced ultrafiltration products…